BIM
COLL icon

Bogle Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

Bogle Investment Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-121,040
Closed -$1.98M – 331
2020
Q1 		$1.98M Buy
121,040
+1,258
+1% +$26K 0.21% 136
2019
Q4 		$2.46M Buy
119,782
+14,154
+13% +$236K 0.23% 129
2019
Q3 		$1.21M Buy
105,628
+21,273
+25% +$243K 0.1% 165
2019
Q2 		$1.11M Sell
84,355
-13,422
-14% -$179K 0.09% 178
2019
Q1 		$1.48M Buy
+97,777
New +$1.57M 0.11% 162

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bogle Investment Management's COLL Position: Q2 2020 in Review

Bogle Investment Management sold out of Collegium Pharmaceutical (COLL) in Q2 2020, closing a stake of 121,040 shares — an estimated $1.98M sold.

Bogle Investment Management first reported a position in COLL in Q1 2019 and held it in 5 quarters. The position peaked at $2.46M in Q4 2019. 150 funds tracked by Wall St. Rank hold COLL as of Q2 2020.

  • Bogle Investment Management reported no remaining Collegium Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • Bogle Investment Management sold 121,040 Collegium Pharmaceutical shares in Q2 2020, an estimated $1.98M.
  • Bogle Investment Management first reported a position in Collegium Pharmaceutical in Q1 2019 and held it in 5 quarters.
  • Bogle Investment Management's Collegium Pharmaceutical position peaked at $2.46M in Q4 2019.
  • 150 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2020.

Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.